Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uterine Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03542513
What this trial is testing

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

Who this might be right for
Cervical Cancer
Universiteit Antwerpen 65
Not applicableStudy completedNCT00788216
What this trial is testing

Development & Validation of Utilities for Health States Relevant to Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Duke University 60
Testing effectiveness (Phase 2)WithdrawnNCT01925378
What this trial is testing

A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia

Who this might be right for
Cervical Dysplasia
The University of Texas Health Science Center, Houston
Not applicableStudy completedNCT01361035
What this trial is testing

Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients

Who this might be right for
Cervical CancerBreast CancerColorectal Cancer
Tulane University School of Medicine 168
Early research (Phase 1)Study completedNCT00028535
What this trial is testing

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial Carcinoma+4 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07497074
What this trial is testing

JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 78
Large-scale testing (Phase 3)Study completedNCT05761418
What this trial is testing

Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy

Who this might be right for
Myoma;Uterus
Beni-Suef University 90
Testing effectiveness (Phase 2)Study completedNCT02428192
What this trial is testing

Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma

Who this might be right for
Metastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT07436793
What this trial is testing

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

Who this might be right for
Endometrial Endometrioid AdenocarcinomaEndometrial Hyperplasia
New Mexico Cancer Research Alliance 140
Not applicableStudy completedNCT06958068
What this trial is testing

Sexual Health Integration in Treatment of Gynecological Oncology

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancers+3 more
Medical University of Silesia 324
Large-scale testing (Phase 3)Study completedNCT02564276
What this trial is testing

Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Centre hospitalier de l'Université de Montréal (CHUM) 132
Not applicableStudy completedNCT04256213
What this trial is testing

COL Immunotherapy Before Radiochimio + Ipilimumab

Who this might be right for
Cervix Cancer
ARCAGY/ GINECO GROUP 40
Testing effectiveness (Phase 2)Study completedNCT04814108
What this trial is testing

Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma

Who this might be right for
Uterine Serous Carcinoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 92
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT06509724
What this trial is testing

Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy

Who this might be right for
Uterine Cervical Neoplasms
Samsung Medical Center 248
Testing effectiveness (Phase 2)Looking for participantsNCT06677190
What this trial is testing

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Who this might be right for
Ovarian CancerOvarian CarcinomaEndometrial Cancer+5 more
Dana-Farber Cancer Institute 32
Not applicableStudy completedNCT01092988
What this trial is testing

A Clinical Study to Evaluate Safety of the ExAblate 2100 UF V2 System in the Treatment of Symptomatic Uterine Fibroids

Who this might be right for
Uterine FibroidsBleedingPain
InSightec 40
Not applicableUnknownNCT06015360
What this trial is testing

Fat Grafting for Vaginal Stenosis in Gynaelogical Cancer

Who this might be right for
Cervical Cancer
Royal Marsden NHS Foundation Trust 8
Not applicableStudy completedNCT01886040
What this trial is testing

Factors Affecting the Prognosis of Patients With Endometrial Cancer

Who this might be right for
Endometrial Cancer
Far Eastern Memorial Hospital 100
Not applicableUnknownNCT00920920
What this trial is testing

An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Medical University of Vienna 1,416
Next Page